News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
6,040 Results
Type
Article (591)
Company Profile (2)
Press Release (5447)
Section
Business (1108)
Career Advice (6)
Deals (227)
Drug Development (541)
Employer Resources (1)
FDA (554)
Job Trends (104)
News (2523)
Policy (225)
Tag
Academia (30)
Accelerated approval (1)
Alliances (259)
Alzheimer's disease (12)
Approvals (559)
Artificial intelligence (7)
Bankruptcy (1)
Best Places to Work (83)
Brain cancer (2)
Breast cancer (3)
Cancer (11)
Cardiovascular disease (20)
Career advice (6)
CAR-T (1)
Cell therapy (1)
Clinical research (516)
Collaboration (4)
Compensation (6)
Complete response letters (2)
COVID-19 (9)
C-suite (8)
Data (79)
Depression (2)
Diabetes (1)
Diagnostics (22)
Digital health (1)
Duchenne muscular dystrophy (3)
Earnings (442)
Employer resources (1)
Events (679)
Executive appointments (7)
FDA (612)
Funding (14)
Gene therapy (7)
GLP-1 (5)
Government (34)
Guidances (6)
Healthcare (101)
Huntington's disease (3)
Immunology and inflammation (3)
Indications (1)
Infectious disease (11)
Inflammatory bowel disease (1)
Intellectual property (2)
Interviews (4)
IPO (61)
Job creations (23)
Job search strategy (3)
Labor market (1)
Layoffs (1)
Legal (30)
Liver cancer (1)
Longevity (1)
Lung cancer (1)
Lymphoma (1)
Management (1)
Manufacturing (3)
Medical device (282)
Medtech (283)
Mergers & acquisitions (180)
Metabolic disorders (26)
Multiple sclerosis (2)
Neuropsychiatric disorders (3)
Neuroscience (49)
NextGen: Class of 2026 (43)
Non-profit (22)
Obesity (24)
Opinion (1)
Parkinson's disease (6)
Patents (9)
Patient recruitment (4)
People (406)
Pharmaceutical (1)
Phase 1 (94)
Phase 2 (201)
Phase 3 (224)
Pipeline (103)
Policy (2)
Postmarket research (53)
Preclinical (40)
Rare diseases (14)
Real estate (24)
Regulatory (242)
Research institute (20)
RNA editing (1)
Schizophrenia (18)
Series A (1)
Series B (3)
Special edition (1)
Sponsored (1)
Startups (21)
Supply chain (1)
The Weekly (3)
Vaccines (5)
Venture capital (2)
Weight loss (5)
Date
Last 7 days (8)
Last 30 days (37)
Last 365 days (295)
2026 (93)
2025 (264)
2024 (293)
2023 (299)
2022 (375)
2021 (394)
2020 (332)
2019 (377)
2018 (286)
2017 (312)
2016 (319)
2015 (374)
2014 (282)
2013 (249)
2012 (265)
2011 (289)
2010 (275)
Location
Africa (1)
Arizona (5)
Asia (141)
Australia (17)
California (95)
Canada (54)
China (4)
Colorado (8)
Connecticut (29)
Delaware (4)
Europe (811)
Florida (6)
Georgia (3)
Illinois (23)
Japan (3)
Kansas (1)
Louisiana (1)
Maine (5)
Maryland (10)
Massachusetts (105)
Michigan (1)
Minnesota (2)
Missouri (4)
Nevada (5)
New Hampshire (1)
New Jersey (21)
New York (11)
North Carolina (48)
Northern California (36)
Ohio (1)
Pennsylvania (29)
South America (7)
South Carolina (12)
Southern California (49)
Tennessee (3)
Texas (8)
United States (436)
Utah (3)
Washington State (2)
6,040 Results for "rhythm".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Obesity
Rhythm’s Imcivree Fails Late-Stage Weight Loss Trial in Rare Obesities
The Phase 3 EMANATE study is a basket trial looking at the efficacy of Rhythm Pharmaceuticals’ injectable obesity drug across four types of obesities driven by specific genetic mutations.
March 17, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Rhythm Pharmaceuticals Announces Changes to Board of Directors
April 5, 2026
·
8 min read
Press Releases
Catheter Precision to Attend the Annual European Heart Rhythm Association Conference
April 8, 2026
·
2 min read
Press Releases
Volta Medical Announces Activities at Heart Rhythm Society 2026 in Chicago, IL, USA
April 7, 2026
·
3 min read
Press Releases
Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026
April 9, 2026
·
7 min read
Press Releases
Rhythm Pharmaceuticals Announces Topline Results from Phase 3 EMANATE Trial
March 16, 2026
·
11 min read
Press Releases
Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity
March 20, 2026
·
13 min read
Approvals
Rhythm Bounces Back from Phase 3 Fail with FDA Nod for Rare Obesity Injection
At its peak, Imcivree’s sales in hypothalamic obesity could reach over $2 billion worldwide, according to analysts at Stifel.
March 20, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Rhythm Pharmaceuticals Announces Participation in Upcoming Guggenheim Biotech Summit
February 5, 2026
·
7 min read
Press Releases
PANTHERx® Rare Selected by Rhythm Pharmaceuticals Inc. as the Exclusive U.S. Specialty Pharmacy for the Expanded Indication for IMCIVREE® (setmelanotide)
March 22, 2026
·
4 min read
1 of 604
Next
